CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 310 enrolled
Drug / intervention
Alclometasone dipropionate creamdrug
Likely dose
Alclometasone dipropionate cream 15 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02075632
NCT02075632Phase 2Completed
CompareCT.gov

A Mult-Center, Open-Label Study to Evaluate Product Duration of Use Experience With Aclometasone Diproprionate Cream

GlaxoSmithKline·interventional·Posted Mar 3, 2014·Updated Sep 5, 2014

In Brief

A Phase 2 clinical trial evaluating Alclometasone dipropionate cream for Eczema and 3 related conditions. Completed, enrolled 310 participants.

Detailed Summary

This is a multi-center, open-label study to evaluate whether participants follow the duration of use instructions for short-term use of alclometasone dipropionate in a population of participants with itchy skin conditions who would use OTC treatments for relief. The study population will be composed of two different cohorts: chronic condition sufferers (eczema or psoriasis) and participants who suffer from occasional itchy skin experiences (such as poison ivy, oak, sumac, insect bites, or skin irritations due to jewelry, cosmetics, detergents, or soaps) where an anti-itch medication would be used.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEczema, Allergy Symptoms, Psoriasis, Itch
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 3, 2014
Enrollment StartSep 1, 2006
Primary CompletionNov 1, 2006
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.3 years ago

Interventions

Alclometasone dipropionate creamdrug

Alclometasone dipropionate cream 0.05% (15 g)